Compound 736
Identifiers
- Canonical SMILES:
FC(F)(F)c1cc(ccc1Sc1ccccc1N1CCCC1)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O
- IUPAC name:
N-[3-(2-oxopyrrolidin-1-yl)propyl]-2-[4-(2-pyrrolidin-1-ylphenyl)sulfanyl-3-(trifluoromethyl)phenyl]cyclopropane-1-carboxamide
- InChi:
InChI=1S/C28H32F3N3O2S/c29-28(30,31)22-17-19(20-18-21(20)27(36)32-12-6-16-34-15-5-9-26(34)35)10-11-24(22)37-25-8-2-1-7-23(25)33-13-3-4-14-33/h1-2,7-8,10-11,17,20-21H,3-6,9,12-16,18H2,(H,32,36)/t20-,21+/m0/s1
- InChiKey:
GVXLMTNNCFPRBM-LEWJYISDSA-N
External links
![]() 168318118 |
![]() 19174440 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 0 | 1 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| LFA / ICAM | 7.49 | immune system disease | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 531.22 g/mol | |||
| HBA | 5 | |||
| HBD | 1 | |||
| HBA + HBD | 6 | |||
| AlogP | 4.51 | |||
| TPSA | 52.65 | |||
| RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 0 | 1 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.5676 | Butaperazine | DB13213 | |
| 0.5524 | Periciazine | DB01608 | |
| 0.5461 | Propiopromazine | DB11540 | |
| 0.5395 | Carphenazine | DB01038 | |
| 0.5271 | Mequitazine | DB01071 | |
| 0.5263 | Etymemazine | DB11517 | |
| 0.5224 | Triflupromazine | DB00508 | |
| 0.5177 | Trifluoperazine | DB00831 | |
| 0.5172 | Fluphenazine | DB00623 | |
| 0.5143 | Acepromazine | DB01614 | |
| 0.5099 | Acetophenazine | DB01063 | |
| 0.5068 | Metopimazine | DB13591 | |
| 0.5034 | Propiomazine | DB00777 | |
| 0.4961 | Methdilazine | DB00902 | |
| 0.4892 | Pyroquilon | DB02756 |




